Literature DB >> 23363003

Development of inhibitors of the PAS-B domain of the HIF-2α transcription factor.

Jamie L Rogers1, Liela Bayeh, Thomas H Scheuermann, Jamie Longgood, Jason Key, Jacinth Naidoo, Lisa Melito, Cameron Shokri, Doug E Frantz, Richard K Bruick, Kevin H Gardner, John B MacMillan, Uttam K Tambar.   

Abstract

pan class="Disease">Hypoxia inducible factors (HIFs) are heterodimeric transcripn>tion factors induced in a variety of pathopn>hysiological settings, including n>an class="Disease">cancer. We describe the first detailed structure-activity relationship study of small molecules designed to inhibit HIF-2α-ARNT heterodimerization by binding an internal cavity of the HIF-2α PAS-B domain. Through a series of biophysical characterizations of inhibitor-protein interactions (NMR and X-ray crystallography), we have established the structural requirements for artificial inhibitors of the HIF-2α-ARNT PAS-B interaction. These results may serve as a foundation for discovering therapeutic agents that function by a novel mode of action.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23363003      PMCID: PMC3676484          DOI: 10.1021/jm301847z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

1.  The LOV domain family: photoresponsive signaling modules coupled to diverse output domains.

Authors:  Sean Crosson; Sudarshan Rajagopal; Keith Moffat
Journal:  Biochemistry       Date:  2003-01-14       Impact factor: 3.162

2.  Luminescent oxygen channeling assay (LOCI): sensitive, broadly applicable homogeneous immunoassay method.

Authors:  E F Ullman; H Kirakossian; A C Switchenko; J Ishkanian; M Ericson; C A Wartchow; M Pirio; J Pease; B R Irvin; S Singh; R Singh; R Patel; A Dafforn; D Davalian; C Skold; N Kurn; D B Wagner
Journal:  Clin Chem       Date:  1996-09       Impact factor: 8.327

Review 3.  Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Trends Pharmacol Sci       Date:  2012-03-06       Impact factor: 14.819

4.  Functions of the Per/ARNT/Sim domains of the hypoxia-inducible factor.

Authors:  Jinsong Yang; Lei Zhang; Paul J A Erbel; Kevin H Gardner; Kan Ding; Joseph A Garcia; Richard K Bruick
Journal:  J Biol Chem       Date:  2005-08-29       Impact factor: 5.157

5.  Evolution of a fourth generation catalyst for the amination and thioetherification of aryl halides.

Authors:  John F Hartwig
Journal:  Acc Chem Res       Date:  2008-11-18       Impact factor: 22.384

6.  Thiol ester-linked p-coumaric acid as a new photoactive prosthetic group in a protein with rhodopsin-like photochemistry.

Authors:  W D Hoff; P Düx; K Hård; B Devreese; I M Nugteren-Roodzant; W Crielaard; R Boelens; R Kaptein; J van Beeumen; K J Hellingwerf
Journal:  Biochemistry       Date:  1994-11-29       Impact factor: 3.162

7.  Artificial ligand binding within the HIF2alpha PAS-B domain of the HIF2 transcription factor.

Authors:  Thomas H Scheuermann; Diana R Tomchick; Mischa Machius; Yan Guo; Richard K Bruick; Kevin H Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-07       Impact factor: 11.205

Review 8.  Evaluation of HIF-1 inhibitors as anticancer agents.

Authors:  Gregg L Semenza
Journal:  Drug Discov Today       Date:  2007-09-18       Impact factor: 7.851

9.  Allosteric inhibition of hypoxia inducible factor-2 with small molecules.

Authors:  Thomas H Scheuermann; Qiming Li; He-Wen Ma; Jason Key; Lei Zhang; Rui Chen; Joseph A Garcia; Jacinth Naidoo; Jamie Longgood; Doug E Frantz; Uttam K Tambar; Kevin H Gardner; Richard K Bruick
Journal:  Nat Chem Biol       Date:  2013-02-24       Impact factor: 15.040

Review 10.  Development of HIF-1 inhibitors for cancer therapy.

Authors:  Barbara Onnis; Annamaria Rapisarda; Giovanni Melillo
Journal:  J Cell Mol Med       Date:  2009-08-08       Impact factor: 5.310

View more
  44 in total

Review 1.  Advances in targeting 'undruggable' transcription factors with small molecules.

Authors:  Matthew J Henley; Angela N Koehler
Journal:  Nat Rev Drug Discov       Date:  2021-05-18       Impact factor: 84.694

Review 2.  Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.

Authors:  Ales Vicha; David Taieb; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2014-05-08       Impact factor: 5.678

3.  William Kaelin, Peter Ratcliffe, and Gregg Semenza receive the 2016 Albert Lasker Basic Medical Research Award.

Authors:  Jillian H Hurst
Journal:  J Clin Invest       Date:  2016-09-13       Impact factor: 14.808

4.  Coiled-coil coactivators play a structural role mediating interactions in hypoxia-inducible factor heterodimerization.

Authors:  Yirui Guo; Thomas H Scheuermann; Carrie L Partch; Diana R Tomchick; Kevin H Gardner
Journal:  J Biol Chem       Date:  2015-01-27       Impact factor: 5.157

5.  Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma.

Authors:  Kevin D Courtney; Jeffrey R Infante; Elaine T Lam; Robert A Figlin; Brian I Rini; James Brugarolas; Naseem J Zojwalla; Ann M Lowe; Keshi Wang; Eli M Wallace; John A Josey; Toni K Choueiri
Journal:  J Clin Oncol       Date:  2017-12-19       Impact factor: 44.544

6.  Molecular modeling of the AhR structure and interactions can shed light on ligand-dependent activation and transformation mechanisms.

Authors:  Laura Bonati; Dario Corrada; Sara Giani Tagliabue; Stefano Motta
Journal:  Curr Opin Toxicol       Date:  2017-02-01

Review 7.  Pheochromocytoma: Gasping for Air.

Authors:  Ivana Jochmanová; Zhengping Zhuang; Karel Pacak
Journal:  Horm Cancer       Date:  2015-07-03       Impact factor: 3.869

8.  Targeting renal cell carcinoma with a HIF-2 antagonist.

Authors:  Wenfang Chen; Haley Hill; Alana Christie; Min Soo Kim; Eboni Holloman; Andrea Pavia-Jimenez; Farrah Homayoun; Yuanqing Ma; Nirav Patel; Paul Yell; Guiyang Hao; Qurratulain Yousuf; Allison Joyce; Ivan Pedrosa; Heather Geiger; He Zhang; Jenny Chang; Kevin H Gardner; Richard K Bruick; Catherine Reeves; Tae Hyun Hwang; Kevin Courtney; Eugene Frenkel; Xiankai Sun; Naseem Zojwalla; Tai Wong; James P Rizzi; Eli M Wallace; John A Josey; Yang Xie; Xian-Jin Xie; Payal Kapur; Renée M McKay; James Brugarolas
Journal:  Nature       Date:  2016-09-05       Impact factor: 49.962

Review 9.  Current and future trends in the anatomical and functional imaging of head and neck paragangliomas.

Authors:  David Taïeb; Arthur Varoquaux; Clara C Chen; Karel Pacak
Journal:  Semin Nucl Med       Date:  2013-11       Impact factor: 4.446

Review 10.  A new paradigm for GERD pathogenesis. Not acid injury, but cytokine-mediated inflammation driven by HIF-2α: a potential role for targeting HIF-2α to prevent and treat reflux esophagitis.

Authors:  Rhonda F Souza; Liela Bayeh; Stuart J Spechler; Uttam K Tambar; Richard K Bruick
Journal:  Curr Opin Pharmacol       Date:  2017-11-05       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.